Towa International

We had the opportunity of participating in the "Diversity as a Strategic Asset" event, organized by Grant Thornton España and Cambra de Barcelona, where our Chief People, Sustainability & Transformation Officer, Meritxell Ferraté, spoke as a panelist.   We often talk about ROI (Return on Investment), but what if we redefine it as Result of Ignoring? Ignoring the ongoing changes in #DIVERSITY within organizations is not an option, we must step up as active agents of change and transformation, we must take care of #OurPeople in every way.   During the panel, we shared how diversity has been a strategic pillar at Towa International from the very start of our cultural transformation. We introduced our #BeGenuine program, which aligns with our internal purpose: caring for people’s health and well-being. Cultural diversity and having diverse teams fuels creativity, analytical thinking, and lateral problem-solving. That’s why it’s an essential part of our value proposition, deeply embedded in our core values and daily decision-making.   We also highlighted how we have implemented #LGTBIQA+ initiatives within #BeGenuine program, just as we have with other diversity clusters, using four key drivers of change to ensure cultural #transformation reaches every part of the company: Shifting from storytelling to #storydoing, because actions speak louder than words; ensuring co-creation by involving our people at every step; #empowering leaders by strengthening our Sustainable Leader model through training and leading by example. And, of course, recognizing that transformation is a collective effort; making strategic alliances a key pillar of success.   We would like to extend a special thank you to the entire Towa community and recognize the joint efforts made, and Grant Thornton España and Cambra de Barcelona for inviting us to be part of this essential conversation 💚   #FromTowaToTheWorld #HealthyTowa #HealthyPeople #ThePlaceToStay

We’re thrilled to announce that we will be participating in #Lynx2Market / #PharmaSynergy, taking place in London from February 27th to 28th! At Towa, we look forward to meeting new partners who share our IKIGAI and dedication to contributing to people's health. We strive to make high-quality generic medicines accessible to as many people as possible, building trusted partnerships along the way. ➡️ If you’re attending and you are interested, please schedule a meeting or reach out for more information at towa2b@towapharmaceutical.com We look forward to seeing you there! #FromTowaToTheWorld #Towa2B #PharmaSynergyRx PharmaSynergy at Lynx2Market

We are honored to announce that João Paulo Nascimento, our Chief Commercial Officer B2C Europe, representing Towa Pharmaceutical, S.A., has been elected President of EQUALMED - Associação Portuguesa de Medicamentos pela Equidade em Saúde, a pharmaceutical industry entity representing the sector of generic, biosimilar, and value-added medicines (VAM) for the 2025-2026 biennium.   This appointment strengthens our commitment to equitable access to essential treatments and the development of a more sustainable pharmaceutical sector. #Generic, #biosimilar, and #VAM medicines play a pivotal role in ensuring healthcare accessibility for all, and we are proud to be part of an association that is leading these efforts.   As the newly appointed president, João emphasizes that "pharmaceutical policy in both outpatient and hospital markets must continue to foster accessibility while ensuring the sustainability of all industry stakeholders, especially in today’s post-pandemic and geopolitical landscape."   We extend our gratitude to the outgoing president, Maria Carmo Neves, for her valuable leadership, and look forward to this exciting new chapter. #FromTowaToTheWorld

Five years of contributing to people's health. Five years of generating genuine smiles. Today, we celebrate an important milestone: our 5th anniversary. Like the art of #Shodō, each brushstroke we've made over these years represents progress, intentional change, and a commitment to continuous improvement. A journey inspired by the Japanese philosophy of balance, precision, and purpose— values that drive us every day in our mission to reach as many people as possible, ensuring equitable access to high-quality medicines worldwide. At Towa, we believe that every action contributes to a larger and more meaningful story. Over the past five years, we have been carefully tracing our path, step by step, toward a healthier future. This is not just a celebration of what we've achieved, but a commitment to what lies ahead. Together with our teams, partners, costumers, and communities, we’ve laid the foundations. Now, we take the next step forward in TRACING THE FUTURE. Thank you for being part of our journey 💚 #FromTowaToTheWorld #TracingTheFuture #5Anniversary

Today is a significant day for us and for Breckenridge Pharmaceutical, our U.S. subsidiary. Breckenridge Pharmaceutical has received final FDA approval for Everolimus tablets for oral suspension, AB-rated to AFINITOR DISPERZ®. The ANDA is held by its partner Natco Pharma Limited, India and Breckenridge plans to launch immediately.   This new launch is part of Breckenridge's strategic plan, embodying the company’s short and medium-term strategy of expanding its presence in the institutional channel and enhancing its portfolio. Brian Guy, President and CCO of Breckenridge, emphasizes “This launch not only reinforces our commitment to supporting the U.S. healthcare system but also aligns with Towa International’s mission of reaching as many people as possible worldwide. Additionally, this milestone is further highlighted by the introduction of our first-ever copay assistance program for Everolimus TFOS, continuing our commitment to improving patient access to medications.” 🔗For further details, kindly refer to the press release: https://lnkd.in/dYVbzU3z #Launch #BreckenridgeTOWArdsFuture #FromTowaToTheWorld

At Towa International, we continue to move towards building a more authentic, #inclusive and safe work environment for all people. That's why we are proud to announce our recent incorporation into REDI.LGBTI, an association that leads the promotion of inclusive and discrimination-free work environments. This strategic alliance is part of our LGTBIQA+ Plan, a key initiative within the #BeGenuine program, designed to foster an organizational culture that celebrates diversity and respects each individual's uniqueness. This step reaffirms our mission to build a corporate culture that values individuality and promotes respect for all, working toward a more inclusive future for everyone. #FromTowaToTheWorld #OurPeople

Join us at DCAT (Drug, Chemical & Associated Technologies Association) Week! 🌍 We’re thrilled to announce our participation in #DCATWeek2025, the premier global event for bio/pharmaceutical manufacturing partnerships. 📍 Find us at the meeting rooms #419, #436, and #510 from March 17th to 20th. Schedule a meeting or contact us at hello@towapharmaceutical.com We can’t wait to see you there! #FromTowaToTheWorld

“The future and sustainability of Europe’s healthcare system depend on #generics and the actions we take today.” With this powerful statement, Pablo Magnani, our Chief Operating Officer, concluded his keynote presentation at the “Global Project Management, Portfolio Planning, and Partnerships for Generics & Biosimilars” event organized by Why Summits.   During his presentation, Pablo shared an insightful overview of the generics sector in Europe, emphasizing the value of generic medicines and addressing the key challenges facing the industry. He also showcased the steps we at Towa International are taking to address these challenges through our strategic focus on three pillars: - Supply diversification - Collaboration with government entities across both public and private sectors - Investing in the future   We extend our thanks to all attendees and speakers for their valuable contributions.   #FromTowaToTheWorld #BCGX0125

We are thrilled to announce that Pablo Magnani, our Chief Operating Officer, will be a Keynote Speaker at Global Project Management, Portfolio Planning and Partnerships for Generics & Biosimilars event, organized by Why Summits, taking place in Barcelona on January 22-23.   Pablo's keynote will focus on The Challenges of Generics in Europe, offering valuable insights into how the generics industry can overcome key barriers to ensure its long-term sustainability. We look forward to seeing you at the event and invite you to join us in discussing solutions for a sustainable generics future.   👉 https://lnkd.in/drwPx7aJ #FromTowaToTheWorld #BCGX0125

🌍 Why did Towa Pharmaceutical, our parent company, choose Barcelona-Catalonia for its global HQ?   Catalonia Trade & Investment recently showcased our success story in an interview with our CEO, David Peix. Our CEO shared the key advantages that inspired our shareholder to select Barcelona-Catalonia as the launchpad for Towa’s international expansion.   As David shared: “Catalonia is a pharmaceutical hub in Southern Europe, with a full ecosystem of suppliers, top talent, and good infrastructures.”   Our collaboration with Catalonia Trade & Investment has been key in this journey, and we look forward to continuing our growth together.   🔗 Read the full success story https://lnkd.in/d5vRg333 #FromTowaToTheWorld